Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 2, 1997, Pages 259-261

  Cicogna, Cristina E ^a,b   White, Mary H ^a   Bernard, Edward M ^a   Ishimura, Toshiyuki ^a   Sun, Ming ^a   Tong, William P ^a   Armstrong, Donald ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLUS FUMIGATUS; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG TISSUE LEVEL; INHALATIONAL DRUG ADMINISTRATION; LUNG ASPERGILLOSIS; MALE; MORTALITY; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT;

EID: 0031039599     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.2.259     Document Type: Article

References (17)

1. Allen, S. D., K. N. Sorensen, M. J. Nejdl, C. Durrant, and R. T. Proffitt. 1994. Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B in murine pulmonary aspergillosis. J. Antimicrob. Chemother. 34:1001-1013.
2. Anaissie, E. J., M. White, O. Uzun, C. Singer, G. P. Bodey, D. Matzke, N. Azarnia, and G. Lopez-Berestein. 1995. Amphotericin B lipid complex (ABLC) versus amphotericin B (AmB) for treatment of hematogenous and invasive candidiasis: a prospective,. randomized, multicenter trial, abstr. LM21, p. 330. In Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Beyer, J., G. Barzen, G. Risse, C. Weyer, K. Miksits, K. Dullenkopf, D. Huhn, and W. Siegert. 1993. Aerosol amphotericin B for the prevention of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 37:1367-1369.
4. Christiansen, K. J., E. M. Bernard, J. W. M. Gold, and D. Armstrong. 1985. Distribution and activity of amphotericin B in humans. J. Infect. Dis. 152: 1037-1043.
5. Clark, J. M., R. R. Whitney, S. J. Olsen, R. J. George, M. R. Swerdel, L. Kunselman, and D. P. Bonner. 1991. Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob. Agents Chemother. 35:615-621.
6. Gondal, J. A., R. P. Swartz, and A. Rahman. 1989. Therapeutic evaluation of free liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice. Antimicrob. Agents Chemother. 33:1544-1548.
7. Gryn, J., J. Goldberg, E. Johnson, J. Siegel, and J. Inzerillo. 1993. The toxicity of daily inhaled amphotericin B. Am. J. Clin. Oncol. 16:43-46.
8. Heinemann, V. P., P. Scolz, and U. Jehn. 1992. Inhalation of amphotericin B as prophylactic antifungal treatment during intensive leukemia therapy. Ann. Hematol. 78:A110. (Abstr. 144.)
9. Lopez-Berestein, G., G. P. Bodey, V. Fainstein, M. Keating, L. S. Frankel, B. Zeluff, L. Gentry, and K. Metha. 1989. Treatment of systemic fungal infections with liposomal amphotericin B. Arch. Intern. Med. 149:2533-2536.
10. Meyer, R. D., L. S. Young, D. Armstrong, and B. Yu. 1973. Aspergillosis complicating neoplastic disease. Am. J. Med. 56:6-15.
11. Myers, M. A., R. W. Niven, L. Straub, H. Schreier, and R. J. Gonzalez-Rothi. 1990. Alveolar macrophage profiles in mice chronically exposed to liposome aerosols. Am. Rev. Respir. Dis. 141:A675.
12. Niki, Y., E. M. Bernard, H. J. Schmitt, W. P. Tong, F. F. Edwards, and D. Armstrong. 1990. Pharmacokinetics of aerosol amphotericin B in rats. Antimicrob. Agents Chemother. 34:29-32.
13. O'Donnell, M. R., G. M. Schmidt, B. R. Tegtmeier, C. Faucett, J. L. Fahey, J. Ito, A. Nademanee, J. Niland, P. Parker, E. P. Smith, D. S. Snyder, A. S. Stein, K. G. Blume, and S. J. Forman. 1994. Prediction of systemic fungal infection in allogeneic marrow transplant recipients: impact of amphotericin B prophylaxis in high-risk patients. J. Clin. Oncol. 12:827-834.
14. Schmitt, H. J., E. M. Bernard, M. Hauser, and D. Armstrong. 1988. Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosis. Antimicrob. Agents Chemother. 32:1676-1679.
15. Schreier, H. 1992. Liposome aerosols. J. Liposome Res. 2(2):145-184.
16. Sorensen, K. N., S. D. Allen, M. J. Nejdl, and R. T. Proffitt. 1993. Aerosolization of liposomal (AmBisome) and non-liposomal (Fungizone) amphotericin B as a treatment for pulmonary fungal infections, p. 187. In Proceedings of the Sixth International Symposium on Recent Advances in Drug Delivery Systems Abstracts. University of Utah, Salt Lake City.
17. Thomas, D. A., M. A. Myers, B. M. Wichert, H. Schreier, and R. J. Gonzalez-Rothi. 1991. Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers. Chest 99:1268-1270.